Conferences and symposiums Inauguration Symposium for Theranostics Trial Center

05-05-2025 8:30 am - 4:30 pm Add to iCal
Karolinska University Hospital, Solna Sune Bergströms aula J3:07, BioClinicum, Solnavägen 30
Collage of images describing the activities at the Theranostics Trial Center.
Teranostics Trial Center. Photo: N/A

Theranostics: Multidisciplinary Insights and Future Directions

You are here invited to an Inauguration Symposium for Theranostics Trial Center. Welcome!

Target audience: Scientists, researchers, clinicians, policymakers, regulatory agents, patient representatives

Purpose: to provide a current state-of-the-art, inspiring future glimpse of new developments in the field of radiopharmaceuticals and showcase activities within the TTC.

The upcoming symposium will bring together national and international experts in the field of onco-theranostics, including pre-clinical and translational researchers, nuclear medicine specialists, oncologists, radiologists, medical physicists and representatives of Swedish pharmaceutical companies, patient organizations and decision-makers.  Topics include advancements in targeting substances for diagnostic and therapeutic purposes, dosimetry, whole-body PET, and clinical applications. See the program below

The symposium is free of charge. Register to secure your attendance and submit abstract for poster session.

The organization committee consists of Rimma Axelsson, Cecilia Hindorf, Antonios Tzortzakakis and Thuy Tran.

Preliminary program

From 8.30           Coffee, registration

9.00-9.15            Welcome

Rimma Axelsson, Professor Nuclear Medicine, Founder of TTC
Mathias Axelsson, Head of Medical Diagnostics Karolinska University Hospital
Lars Holmgren, Professor and Head of Department of Oncology-Pathology

9.20-10.00          State-of-the-art overview of theranostics: use in clinical practice and ongoing trials

Désirée Deandreis, Professor, chief of the nuclear medicine division at Gustave Roussy and University of Turin, France

10.00-10.30       Coffee and posters

10.30-11.00       Development of protein-based theranostic pairs from an industrial perspective

Fredrik Frejd, Professor Uppsala University and CFO Affibody AB Sweden. 

11.00-11.15       Theranostic trials in pediatric oncology

Jakob Stenman, Associate professor Karolinska Institutet and Pediatric surgeon at Karolinska University Hospital, Stockholm, Sweden

11.15 -11.30      Starting early-stage clinical trials with radiopharmaceuticals

Renske Altena,  Associate professor, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

11.30-12.30       Lunch and posters 

12.30-13.00       Physicist perspective – dosimetry of new radiotheranostic products 

Caroline Stokke, Professor and Head of Nuclear Medicine & PET Physics, Oslo University Hospital, Norway

13.00- 13.30      At-221 and beyond 

Stig Palm, Associate professor, Department of Radiation Physics, Sahlgrenska Academy at the    University of Gothenburg, Gothenburg, Sweden

13.30-14.00          Advances and future perspectives of 161-Tb-labelled radiopharmaceuticals.                        

Christina Müller, Professor Paul Scherrer Institute, Center for Radiopharmaceutical Sciences, Switzerland

14.00-14.30       Coffee and poster

14.30-15.15       New possibilities with whole body PET-cameras

Adrienne H Brouwers, Professor Department of Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, The Netherlands                    

15.15-16.00       Panel Discussion 

16.00-16.15       Concluding Remarks and Poster Prize